Načítá se...
5PSQ-045 Cost-effectiveness analysis of isavuconazole versus voriconazole
BACKGROUND: To insert a drug into the Hospital Pharmaceutical Formulary (HPF) it is necessary to carry out a drug-economic analysis. The health economics study offers analysis tools such as Net Monetary Benefit (NMB) and Incremental Cost-Effectiveness Ratio (ICER) are useful in making these decision...
Uloženo v:
| Vydáno v: | Eur J Hosp Pharm |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535613/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.399 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|